Viewing Study NCT00017394


Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2025-12-27 @ 4:55 AM
Study NCT ID: NCT00017394
Status: COMPLETED
Last Update Posted: 2013-01-17
First Post: 2001-06-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module